Predictors of the Long-term Functional Benefits of a Pulmonary Rehabilitation Program?

Hopital du Sacre-Coeur de Montreal5 sites in 1 country360 target enrollmentMay 2015

ConditionsChronic Obstructive Pulmonary Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Chronic Obstructive Pulmonary Disease
Sponsor: Hopital du Sacre-Coeur de Montreal
Enrollment: 360
Locations: 5
Primary Endpoint: The change in exercise tolerance at 1-year post-PR
Status: Suspended
Last Updated: 7 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The present study aims to assess the prevalence and impact of comorbid psychiatric disorders among patients with chronic obstructive pulmonary disease (COPD) undergoing pulmonary rehabilitation (PR), in order to determine the effects of psychiatric comorbidity on exercise tolerance and physical activity post-PR and HRQoL, as well as to determine the processes by which these psychiatric disorders may impact on these patient behaviours.

Registry

clinicaltrials.gov

Start Date

May 2015

End Date

March 2023

Last Updated

7 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Hopital du Sacre-Coeur de Montreal

Responsible Party

Principal Investigator

Grégory Moullec

Researcher

Hopital du Sacre-Coeur de Montreal

Eligibility Criteria

Inclusion Criteria

•Patients over the age of 40 will be eligible if
•they are diagnosed with moderate-severe COPD,
•currently participate to a PR program, and
•agree to participate.

Exclusion Criteria

•They will be excluded if:
•they have any comorbidity that is more important (i.e., more likely to cause morbidity or mortality) than COPD (e.g., active cancer),
•they have contraindications to exercise (though they will not likely be referred to PR),
•they have participated in a PR program in the past year,
•and if they are unable to provide informed consent due to language difficulties or cognitive impairment.

Outcomes

Primary Outcomes

The change in exercise tolerance at 1-year post-PR

Time Frame: Participants will be evaluated at 3 time points: (1) post-PR; (2) at 6-mo; (3) at 12-mo follow-up.

Exercise tolerance will be measured with the 6-minute walking test (6MWT).

Secondary Outcomes

The change in health-related quality of life (HRQoL) at 1-year post-PR(Participants will be evaluated at 3 time points: (1) post-PR; (2) at 6-mo; (3) at 12-mo follow-up.)